Literature DB >> 136183

The clinical course of primary myocardial disease in infants and children.

R D Greenwood, A S Nadas, D C Fyler.   

Abstract

A total of 161 infants and children, ranging in age from 1 day to 17 years at initial encounter (mean, 3.7 years), was seen over a 30 year period with primary myocardial disease (idiopathic myocarditis, nonobstructive cardiomyopathy, endocardial fibroelastosis, and an anatomically unknown category). These patients were observed from 1 hour to 23 years after initial encounter and cardiac disease has resolved in 27 per cent, resulted in death in 35 per cent, and continues in 38 per cent. The majority were first referred to us with congestive heart failure; all exhibited ST-T changes and cardiomegaly, 67 of 150 had left ventricular hypertrophy, 23 of 151 arrhythmias, and 55 of 153 pulmonary vascular congestion. Initial ventricular depolarization abnormalities were very frequent. Significant clinical predictors of fatal outcome included pulmonary vascular congestion, "northwest" axis deviation, and a cardiac index less than three L./min./M.2. Death occurred during the first year after initial encounter in 44 of 57 who died, and in all 13 with proved myocarditis. Primary myocardial disease is a serious disease of infancy and childhood, resulting in death or residual cardiac disease in three fourths of those affected.

Entities:  

Mesh:

Year:  1976        PMID: 136183     DOI: 10.1016/s0002-8703(76)80074-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.

Authors:  J Soongswang; C Sangtawesin; K Durongpisitkul; D Laohaprasitiporn; A Nana; K Punlee; C Kangkagate
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  The myocardium of fetuses with endocardial fibroelastosis contains fewer B and T lymphocytes than normal control myocardium.

Authors:  Nisha M Fernandes; Glenn P Taylor; Cedric Manlhiot; Brian W McCrindle; Michael Ho; Steven E S Miner; Adelle Atkinson; Edgar T Jaeggi; Lynne E Nield
Journal:  Pediatr Cardiol       Date:  2011-04-12       Impact factor: 1.655

4.  Comparison of Immune Profiles in Fetal Hearts with Idiopathic Dilated Cardiomyopathy, Maternal Autoimmune-Associated Dilated Cardiomyopathy and the Normal Fetus.

Authors:  Lynne E Nield; Ingo von Both; Najla Popel; Kate Strachan; Cedric Manlhiot; Patrick Shannon; Brian W McCrindle; Adelle Atkinson; Steven E S Miner; Edgar T Jaeggi; Glenn P Taylor
Journal:  Pediatr Cardiol       Date:  2015-10-20       Impact factor: 1.655

5.  Cardiac function assessment in patients with family history of nonhypertrophic cardiomyopathy: a prenatal and postnatal study.

Authors:  S R F F Pedra; L K Hornberger; S M Leal; G P Taylor; J F Smallhorn
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

6.  Primary myocardial disease (cardiomyopathies): a study of 69 cases.

Authors:  R K Menon; R Tandon; S Shrivastava
Journal:  Indian J Pediatr       Date:  1987 Jan-Feb       Impact factor: 1.967

7.  Prediction of outcome in dilated cardiomyopathy.

Authors:  R A Diaz; A Obasohan; C M Oakley
Journal:  Br Heart J       Date:  1987-10

8.  Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review.

Authors:  Jorge A Alvarez; James D Wilkinson; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2007-09-01

9.  Reversible cardiomyopathy caused by an uncommon form of congenital adrenal hyperplasia.

Authors:  A S Al Jarallah
Journal:  Pediatr Cardiol       Date:  2004 Nov-Dec       Impact factor: 1.655

10.  The usefulness of surface electrocardiogram as a prognostic predictor in children with idiopathic dilated cardiomyopathy.

Authors:  June Huh; Chung Il Noh; Yong Soo Yun
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.